搜索筛选:
搜索耗时0.0908秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
[会议论文] 作者：Zhe Yang,Huiyan Luo,Yingqin Li,Jie Liu,
来源：The First International Symposium on Translational Nanomedic 年份：2015
Gastric cancer(GC)is the fourth most common cancer in the world and is the second-leading cause of cancer death....
Oxaliplatin, Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recur
[期刊论文] 作者：Bing Han,Ruihua Xu,Yanxia Shi,Huiyan Luo,Xiaojuan Xiang,Yuhong Li,Li Zhang,Tongyu Lin,Youjian He,
来源：中国肿瘤临床（英文版） 年份：2004
OBJECTIVE To investigate the efficiency and safety of the oxaliplatin,fluorouracil (5-FU) and leucovorin regimen (FOLFOX) in previously untreated patients with...
Suppression of Fumarate Hydratase Augments the Efficacy of Cisplatin-mediated Chemotherapy in Gastri
[会议论文] 作者：Hongen Yu,Huiyan Luo,Feng Wang,Fang Yu,Zhao-lei Zeng,Yun Wang,Yun-xin Lu,Ying Jin,Huai-Qiang Ju,Rui-hua,
来源：2019中国肿瘤学大会 年份：2019
Objective Gastric cancer(GC)is one of the most common malignancies worldwide.Due to the low rate of early detection,most GC patients were diagnosed as advance stages and had poor response to chemother...
Continuing single-agent capecitabin as maintenance therapy after induction of XELOX (or FOLFOX) in f
[会议论文] 作者：Ruihua Xu,Yuhong Li,Huiyan Luo,Wei Wang,Zhiqiang Wang,Xia Yuan,Dong Ma,Fenghua Wang,Dongshen Zhang,Daren,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Colorectal cancer (CRC) is one of the most common malignant tumors.Most of advanced CRC will progress after first-line treatment;therefore, seeking an efficient and low toxic maintaining re...
相关搜索：
